April 03, 2026 06:42 pm (IST)
Antibiotics
New UTI test could save lives by stopping wrong antibiotic use, reveal scientists
Scientists say a rapid test that identifies which antibiotics will work for urinary tract infections by testing directly from urine samples could allow same-day prescribing and reduce unnecessary antibiotic use — a key driver of antibiotic resistance.
Patients with urinary tract infections (UTIs) could receive the right antibiotic far sooner, thanks to a new test that produces results within hours rather than days.
Researchers at the University of Reading, the University of Southampton and Hampshire Hospitals NHS Foundation Trust, have shown that a novel method testing directly from urine can tell doctors which antibiotic will work in an average of 5.85 hours. Standard laboratory testing currently takes two to three days.
The study funded by the National Institute for Health and Care Research (NIHR), published in the Journal of Antimicrobial Chemotherapy , tested 352 urine samples from patients with suspected UTIs.
Researchers at the University of Reading, the University of Southampton and Hampshire Hospitals NHS Foundation Trust, have shown that a novel method testing directly from urine can tell doctors which antibiotic will work in an average of 5.85 hours. Standard laboratory testing currently takes two to three days.
The study funded by the National Institute for Health and Care Research (NIHR), published in the Journal of Antimicrobial Chemotherapy , tested 352 urine samples from patients with suspected UTIs.
Antibiotics for treating UTI
The new test agreed with the reference method in 96.95 percent of cases for seven first line antibiotics for treating UTI. Crucially a second study of 90 duplicate samples showed 98.75 percent agreement for direct-from-urine testing when collecting and storing urine samples with and without a preservative, read the University of Southampton website.
Dr Oliver Hancox, Chief Executive Officer of Astratus Limited, the University of Reading spin-out company that will take the test to market, said: “By the time the laboratory delivers the result under current methods, a patient may already have finished their antibiotics, or been given ones that do not work.
“Being able to tell a doctor the same day which antibiotic to use means the patient gets the right treatment sooner, reducing the risk of resistance developing and their infection turning into potentially lethal sepsis.”
Professor Mike Lewis, NIHR Scientific Director for Innovation, said: "This NIHR-funded research not only has the potential to deliver quicker, more effective treatments to patients suffering with UTIs - but also tackles the broader challenge of antimicrobial resistance. The rapid urine test is a fantastic example of the real-world solutions to AMR that the government committed to developing in its 10-Year Health Plan."
Dr Al Edwards , of the University of Southampton and Astratus Limited, is a lead author on the paper.
Direct-from-urine testing
NHS data shows that UTIs have led to more than 800,000 hospital admissions across England over the past five years and a quarter of urine samples analysed in NHS laboratories contained bacteria resistant to commonly used antibiotics. Approximately 65 million urine samples are tested annually in the UK alone.
Under current methods, a urine sample must be cultured overnight so the bacteria can grow and be identified before any antibiotic testing begins, a process that can take two to three days in total.
This new test skips the overnight step entirely and involves simple sample processing. A cartridge of fine tubes, each pre-loaded with different antibiotics, is dipped directly into the sample and loaded into an instrument. Optical imaging then tracks whether bacterial growth is detected or not in each tube. If growth is blocked, that antibiotic works against the infection. If bacteria continue to grow, it does not. This tells doctors which drug to prescribe, in under six hours.
Professor Matthew Inada-Kim, researcher at the University of Southampton and consultant acute physician and AMR Lead at Hampshire Hospitals NHS Foundation Trust, said: "UTIs are a common reason that patients need antibiotics, and getting the right treatment first time could be a lifesaver.
“A test that works on samples we already collect as standard, and gives us answers the same day, is exactly the kind of tool that could change how we manage these infections in practice."
First-of-its-kind study
In the study, 352 urine samples already collected as part of routine laboratory testing at Basingstoke and North Hampshire Hospital were used to assess the overall accuracy of direct-from-urine testing. To evaluate whether the use of boric acid preservative, routinely used when collecting and storing urine samples, affected results, 90 fresh samples from the hospital emergency department were split in two duplicate samples, boric acid was added to one set of samples.
Results agreed in 98.75 percent of cases, showing that the preservative does not affect result accuracy. This is the first study to directly compare urine samples with or without boric acid to assess the impact of the preservative on a rapid direct-from-urine method.
The new test agreed with the reference method in 96.95 percent of cases for seven first line antibiotics for treating UTI. Crucially a second study of 90 duplicate samples showed 98.75 percent agreement for direct-from-urine testing when collecting and storing urine samples with and without a preservative, read the University of Southampton website.
Dr Oliver Hancox, Chief Executive Officer of Astratus Limited, the University of Reading spin-out company that will take the test to market, said: “By the time the laboratory delivers the result under current methods, a patient may already have finished their antibiotics, or been given ones that do not work.
“Being able to tell a doctor the same day which antibiotic to use means the patient gets the right treatment sooner, reducing the risk of resistance developing and their infection turning into potentially lethal sepsis.”
Professor Mike Lewis, NIHR Scientific Director for Innovation, said: "This NIHR-funded research not only has the potential to deliver quicker, more effective treatments to patients suffering with UTIs - but also tackles the broader challenge of antimicrobial resistance. The rapid urine test is a fantastic example of the real-world solutions to AMR that the government committed to developing in its 10-Year Health Plan."
Dr Al Edwards , of the University of Southampton and Astratus Limited, is a lead author on the paper.
Direct-from-urine testing
NHS data shows that UTIs have led to more than 800,000 hospital admissions across England over the past five years and a quarter of urine samples analysed in NHS laboratories contained bacteria resistant to commonly used antibiotics. Approximately 65 million urine samples are tested annually in the UK alone.
Under current methods, a urine sample must be cultured overnight so the bacteria can grow and be identified before any antibiotic testing begins, a process that can take two to three days in total.
This new test skips the overnight step entirely and involves simple sample processing. A cartridge of fine tubes, each pre-loaded with different antibiotics, is dipped directly into the sample and loaded into an instrument. Optical imaging then tracks whether bacterial growth is detected or not in each tube. If growth is blocked, that antibiotic works against the infection. If bacteria continue to grow, it does not. This tells doctors which drug to prescribe, in under six hours.
Professor Matthew Inada-Kim, researcher at the University of Southampton and consultant acute physician and AMR Lead at Hampshire Hospitals NHS Foundation Trust, said: "UTIs are a common reason that patients need antibiotics, and getting the right treatment first time could be a lifesaver.
“A test that works on samples we already collect as standard, and gives us answers the same day, is exactly the kind of tool that could change how we manage these infections in practice."
First-of-its-kind study
In the study, 352 urine samples already collected as part of routine laboratory testing at Basingstoke and North Hampshire Hospital were used to assess the overall accuracy of direct-from-urine testing. To evaluate whether the use of boric acid preservative, routinely used when collecting and storing urine samples, affected results, 90 fresh samples from the hospital emergency department were split in two duplicate samples, boric acid was added to one set of samples.
Results agreed in 98.75 percent of cases, showing that the preservative does not affect result accuracy. This is the first study to directly compare urine samples with or without boric acid to assess the impact of the preservative on a rapid direct-from-urine method.
#rapid UTI test
# urinary tract infection antibiotic test
# fast antibiotic sensitivity test
# same day UTI diagnosis
# antibiotic resistance breakthrough
# NHS UTI research UK
# University of Reading UTI study
# University of Southampton infection test
# Astratus rapid urine test
# antimicrobial resistance solution
# UTIs treatment innovation
# direct from urine testing antibiotics
# faster lab diagnosis infection
# sepsis prevention UTI treatment
# NIHR funded UTI research
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Is sitting the new danger? Experts issue heart warning
Wed, Apr 01 2026
Abdominal or central obesity is a greater risk factor compared to overall obesity: Indian Minister
Sun, Mar 29 2026
Big move in healthcare! IIT Kharagpur, Charnock Hospital unite for advance research, clinical excellence
Fri, Mar 27 2026
Dying with dignity: India’s slow, uneasy acceptance of euthanasia
Wed, Mar 25 2026
